Close

Questcor Pharma (QCOR) to Hold Conf. Call Following 48% Dive on Acthar Concerns

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. HCP
6. SPY
7. BSX
8. NOW
9. PI
10. ORCL


Go back to Questcor Pharma (QCOR) to Hold Conf. Call Following 48% Dive on Acthar Concerns

Questcor (QCOR) Comments on Insurance Policy Bulletin; Does Not See Material Impact

September 19, 2012 2:37 PM EDT

Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today commented on information regarding an insurance policy bulletin issued with respect to the Company's primary product H.P. Acthar® Gel (repository corticotropin injection) ("Acthar").

The Company is continuing to review the Clinical Policy Bulletin related to Acthar... More

Questcor Pharmacueticals (QCOR) Slammed 34% On Reports Aetna Insurance Coverage Dropped

September 19, 2012 10:29 AM EDT

Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) is now down 34 percent on reports from Citron Research that Aetna dropped coverage of key drug Acthar.

According to Cintron:
One of the largest managed care providers in the United States, Aetna has disclosed that... More

Questcor Pharmaceuticals (QCOR) Slammed after Citron Notes Aetna Drops Acthar Coverage

September 19, 2012 10:13 AM EDT

Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) is seeing downside after Citron Research notes that Aetna (NYSE: AET) is dropping coverage of key drug Acthar.

According to Cintron:
One of the largest managed care providers in the... More